Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CD164 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBE2D3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
CSNK1A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IQGAP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SNAI2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HIST1H4E - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UBN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KANSL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GAP43 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TJP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACTG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TPSAB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ESR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACSL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PTCRA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PSMD11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
E2F5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FEM1B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRSF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on